Senju Pharmaceutical. has filed a patent for a method and agent to prevent and treat COVID-19 caused by SARS-CoV-2 or its mutant strains. The agent includes a specific compound. GlobalData’s report on Senju Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Senju Pharmaceutical, Nanoparticle drug conjugates was a key innovation area identified from patents. Senju Pharmaceutical's grant share as of January 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.
Covid-19 treatment method using specific compound
A recently filed patent (Publication Number: US20230390235A1) outlines a method for preventing and/or treating COVID-19 by administering at least one compound from a specific group of compounds represented by formula (I). The method is specifically targeted towards individuals infected with SARS-CoV-2 or its mutant strains.
The patent claims specify that the method can be applied to both asymptomatic and symptomatic individuals infected with SARS-CoV-2 or its mutant strains. The mutant strains mentioned include a wide range of variants such as a, ß, ?, d, ?, µ, e, ?, ?, ?, ?, and ? mutant strains. This suggests that the method is designed to address the evolving nature of the virus and its various mutations, providing a potentially comprehensive approach to prevention and treatment. Further research and development based on these claims could lead to novel strategies in combating the ongoing COVID-19 pandemic.
To know more about GlobalData’s detailed insights on Senju Pharmaceutical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
